UK shareholder meetings calendar - next 7 days
6th May 2025 14:14
| Price | 206.00p on 30-05-2025 at 05:00:03 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Buy / Sell HCM Shares | |
| Last Trade: | Sell 1,620.00 at 204.00p |
| Day's Volume: | 0 |
| Last Close: | 206.00p |
| Open: | 0.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 187.50p - 336.00p |
| Market Capitalisation: | £1,761m |
| VWAP: | 0.00p |
| Shares in Issue: | 855m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,620 | 204.00p | Ordinary |
15:50:17 - 29-May-25 |
| Sell* | 1,000 | 203.744p | Ordinary |
15:29:33 - 29-May-25 |
| Buy* | 332 | 207.00p | Automatic Execution |
15:19:25 - 29-May-25 |
| Buy* | 33 | 206.00p | Automatic Execution |
15:19:25 - 29-May-25 |
| Buy* | 135 | 206.00p | Automatic Execution |
15:19:25 - 29-May-25 |
| Sell* | 69 | 203.217p | Negotiated Trade |
15:16:42 - 29-May-25 |
| Sell* | 6 | 203.00p | SI Trade |
15:02:03 - 29-May-25 |
| Buy* | 495 | 203.00p | Automatic Execution |
14:32:41 - 29-May-25 |
| Buy* | 1,000 | 203.00p | Ordinary |
14:30:54 - 29-May-25 |
| Buy* | 1,000 | 202.70p | Ordinary |
13:47:52 - 29-May-25 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd May 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at ASCO |
| 13th May 2025 11:45 am | RNS | AGM held on May 13, 2025 – Poll Results |
| 24th Apr 2025 7:00 am | RNS-R | HUTCHMED - Data to be Presented at AACR 2025 |
| 22nd Apr 2025 7:00 am | RNS-R | HUTCHMED Completes Enrollment of Phase II Study |
| 7th Apr 2025 9:30 am | RNS | 2024 Annual Report and Notice of AGM |
| 31st Mar 2025 10:30 am | RNS | Extraordinary General Meeting – Poll Results |
| 21st Mar 2025 10:00 am | RNS-R | NMPA Conditional Approval for TAZVERIK® |
| 20th Mar 2025 9:30 am | RNS | Retirement of Independent Non-executive Directors |
| 20th Mar 2025 7:00 am | RNS-R | HUTCHMED Highlights Savolitinib SAVANNAH Phase II |
| 19th Mar 2025 1:45 pm | RNS-R | Publication of Form 20-F |